377 results match your criteria: "Weill Cornell Medicine - New York Presbyterian Hospital[Affiliation]"
Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma.
Clin Lymphoma Myeloma Leuk
April 2016
Global Medical Affairs, Pfizer Inc, New York, NY. Electronic address:
Diffuse large B-cell lymphoma (DLBCL), an aggressive non-Hodgkin lymphoma (NHL), is the most-common subtype of NHL. DLBCL can be classified into at least 3 major immunologically distinct types, which contributes to considerable variation in disease prognosis and response to treatment. DLBCL potentially is curable, even when diagnosed at advanced stages.
View Article and Find Full Text PDFHepatosplenic T-Cell Lymphoma Mimicking Acute Myeloid Leukemia.
Clin Lymphoma Myeloma Leuk
March 2016
Division of Hematopathology, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY. Electronic address: